Australia-India Strategic Research Fund Round 13 - COVID-19 Collaborative Research Projects

Overview

The AISRF provides grants for collaborative research projects with Indian partners. For Round 13 of the AISRF, your project must involve research in a COVID-19 focused priority area and must be mutually beneficial for Australia and India with outcomes that contribute to the global response to the COVID-19 pandemic. the minimum grant amount is $300,000 the maximum grant amount is $600,000 the maximum project period is up to twelve months The lead organisation may submit a maximum of 2 applications: one with a corresponding Indian partner application being submitted under the Science and Technology Fund with India's Department of Science and Technology (DST) one with a corresponding Indian partner application being submitted under the Biotechnology Fund with India's Department of Biotechnology (DBT) Round 13 Priority Areas Your project must be in a priority area. The priority areas for Round 13 - COVID 19 Collaborative Research Projects are: Indo-Australian Science & Technology Fund (administered by DST in India) Antiviral coatings, other preventive technologies Data analytics, modelling, Artificial Intelligence applications Screening and diagnostic testing Indo-Australian Biotechnology Fund (administered by DBT in India) Development of immunotherapeutics Development of animal model/ in vitro model for vaccine development Assay development and validation for testing of vaccines and therapeutics Viral genomics and bioinformatics